Ultragenyx Pharmaceutical Inc. (RARE) Kompaniya qiymatining sof foydaga nisbati

Ultragenyx Pharma (RARE) korporativ emblemasi va logotipi

P/E koeffitsiyenti dinamikasi aktivning bozor qiymatini namoyish etadi, bunda -3.10 darajasi joriy miqdorni aks ettiradi. Ultragenyx Pharmaceutical (RARE) mRNA yetkazib berish uchun AI texnologiyalarini joriy etish orqali noyob patologiyalar nishasida ustunlikka intilmoqda. Biroq, sinovlarning qat'iy nazorati va ishlab chiqish xarajatlari budjetga yuk bo'lmoqda. Og'ir bemorlar uchun yuqori narxli dori vositalarining sug'urta qoplamalari barqarorlikni ta'minlaydi.

Ultragenyx Pharmaceutical (RARE): P/E multiplikatori 04.07.2022dan 17.11.2026gacha

Ultragenyx Pharmaceutical kompaniyasining tahliliy kesimlari

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:RARE (Ultragenyx Pharma)
ultragenyx.com original mahsuloti

Ultragenyx Pharmaceutical qat'iy harorat nazoratiga ega bo'lgan kamyob dorilar uchun noyob taqsimot tizimi orqali yuqori marjalarni saqlab qolmoqda. GURU.Markets platformasida kompaniyaning harakatlanuvchi P/E ko'rsatkichini tahlil qilish orqali investor bozor kapitalizatsiyasining biznesning foyda keltirish qobiliyatiga nisbatini kuzatishi mumkin, bu esa kapitalning joriy qiymati logistik aktivlarning samaradorligi va aktivlarning haddan tashqari qizib ketish xatarlari bilan solishtirganda adolatli ekanligini baholash imkonini beradi.

Raqobatdosh kompaniyalar

tempus.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori QGEN|Biznesning o‘zini qoplash muddati Isis Pharmaceuticals|P/E multiplikatori RGEN (repligen.com)|Bozor narxining sof foydaga nisbati RNA (Avidity Biosciences, Inc.)|CRSP - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati WGS (GeneDx)|BEAM: P/E multiplikatori|Sarepta Therapeutics, Inc. (SRPT) - P/E multiplikatori|TWST (twistbioscience.com) - P/E multiplikatori|10x Genomics, Inc. (TXG) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti NTLA (Intellia Therapeutics, Inc.)|STOK - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati biolifesolutions.com BLFS|Biznesning o‘zini qoplash muddati Wave Life Sciences Corp (WVE)|MAZE - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati SION (Sionna Therapeutics Inc)|PRME: P/E multiplikatori|Taysha - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati uniQure NV|Narx-foyda multiplikatori MGTX (MeiraGTx PLC)|Narx-foyda koeffitsiyenti RGNX (regenxbio.com)|Solid Biosciences Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Kapitalizatsiyaning foydaga nisbati|BNTC - Narxning foydaga nisbati|Design Pharma - Bozor narxining sof foydaga nisbati|RCKT (Rocket Pharmaceuticals Inc) - Narx-foyda koeffitsiyenti|4D Molecular Therapeutics (FDMT) - P/E multiplikatori|Narxning foydaga nisbati Lexeo Therapeutics, Inc.|Kapitalizatsiyaning foydaga nisbati Korro Bio, Inc. KRRO|P/E multiplikatori EDIT|Biznesning o‘zini qoplash muddati Silence Therapeutics Corp|Narxning foydaga nisbati proqr.com PRQR|CDXS - Narx-foyda koeffitsiyenti|SGMO - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Nautilus Biotechnology, Inc. (NAUT)|MGX: P/E multiplikatori|Narx-foyda multiplikatori DTIL|GBIO (Generation Bio) - P/E multiplikatori|Narx-foyda multiplikatori BOLD (boundlessbio.com)|Narx-foyda koeffitsiyenti XCUR (exicuretx.com)|Celsion Corporation - Narx-foyda multiplikatori|P/E multiplikatori PHIO (phiopharma.com)|P/E multiplikatori Mustang Bio, Inc. MBIO|RNAZ: Narx-foyda koeffitsiyenti|BNGO (Bionano Genomics) - Narx-foyda multiplikatori|APDN: P/E multiplikatori|bluebird bio (BLUE) - P/E multiplikatori|Narxning foydaga nisbati ImmunoPrecise Antibodies Ltd.|Kapitalizatsiyaning foydaga nisbati Omega OMGA|P/E multiplikatori OMIC|RGLS - Kapitalizatsiyaning foydaga nisbati|Syros Pharmaceuticals, Inc - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Codex DNA (TBIO)|TCON - Narxning foydaga nisbati|UBX: Narxning foydaga nisbati